Patents by Inventor Alkesh KASLIWAL

Alkesh KASLIWAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NANOPARTICULATE FORMULATION COMPRISING AN mPGES-1 INHIBITOR
    Publication number: 20200197370
    Abstract: The present invention relates to a nanoparticulate formulation comprising a microsomal prostaglandin E synthases-1 (“mPGES-1”) inhibitor. Particularly, the present invention relates to a nanoparticulate formulation comprising an mPGES-1 inhibitor and one or more surface stabilizers; a process for preparing such formulation; and its use in treating pain and inflammation in a subject.
    Type: Application
    Filed: July 31, 2019
    Publication date: June 25, 2020
    Inventors: Ulhas R Dhuppad, Sunil Chaudhari, Suresh Rajurkar, Nilesh Jain, Chandrakant Dhatrak, Alkesh Kasliwal
  • Tiotropium inhalation solution for nebulization
    Patent number: 10653683
    Abstract: The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: May 19, 2020
    Assignee: GLENMARK SPECIALTY S.A.
    Inventors: Ulhas R. Dhuppad, Franciscus Koppenhagen, Sunil Chaudhari, Suresh Rajurkar, Chandrakant Dhatrak, Alkesh Kasliwal
  • Tiotropium inhalation solution for nebulization
    Patent number: 10632109
    Abstract: The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: April 28, 2020
    Assignee: GLENMARK SPECIALTY S.A.
    Inventors: Ulhas R. Dhuppad, Franciscus Koppenhagen, Sunil Chaudhari, Suresh Rajurkar, Chandrakant Dhatrak, Alkesh Kasliwal
  • Tiotropium inhalation solution for nebulization
    Patent number: 10632108
    Abstract: The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: April 28, 2020
    Assignee: GLENMARK SPECIALTY S.A.
    Inventors: Ulhas R. Dhuppad, Franciscus Koppenhagen, Sunil Chaudhari, Suresh Rajurkar, Chandrakant Dhatrak, Alkesh Kasliwal
  • TIOTROPIUM INHALATION SOLUTION FOR NEBULIZATION
    Publication number: 20190282551
    Abstract: The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.
    Type: Application
    Filed: June 3, 2019
    Publication date: September 19, 2019
    Inventors: Ulhas R. Dhuppad, Franciscus Koppenhagen, Sunil Chaudhari, Suresh Rajurkar, Chandrakant Dhatrak, Alkesh Kasliwal
  • TIOTROPIUM INHALATION SOLUTION FOR NEBULIZATION
    Publication number: 20190231758
    Abstract: The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.
    Type: Application
    Filed: April 5, 2019
    Publication date: August 1, 2019
    Inventors: Ulhas R. Dhuppad, Franciscus Koppenhagen, Sunil Chaudhari, Suresh Rajurkar, Chandrakant Dhatrak, Alkesh Kasliwal
  • TIOTROPIUM INHALATION SOLUTION FOR NEBULIZATION
    Publication number: 20190105306
    Abstract: The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.
    Type: Application
    Filed: May 7, 2018
    Publication date: April 11, 2019
    Inventors: Ulhas R. Dhuppad, Franciscus Koppenhagen, Sunil Chaudhari, Suresh Rajurkar, Chandrakant Dhatrak, Alkesh Kasliwal
  • Tiotropium inhalation solution for nebulization
    Patent number: 9987260
    Abstract: The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: June 5, 2018
    Assignee: GLENMARK SPECIALTY S.A.
    Inventors: Ulhas Dhuppad, Franciscus Koppenhagen, Sunil Chaudhari, Suresh Rajurkar, Chandrakant Dhatrak, Alkesh Kasliwal
  • NEBULIZED TIOTROPIUM
    Publication number: 20180133151
    Abstract: The present invention relates to therapeutic methods of administering tiotropium using a nebulizer. The present invention also relates to methods of treating inflammatory or obstructive airway diseases by administering a sterile nebulizable composition of tiotropium using a nebulizer.
    Type: Application
    Filed: November 16, 2017
    Publication date: May 17, 2018
    Inventors: Ulhas R Dhuppad, Franciscus Koppenhagen, Julianne Berry, Sunil Chaudhari, Suresh Rajurkar, Chandrakant Dhatrak, Alkesh Kasliwal
  • TIOTROPIUM INHALATION SOLUTION FOR NEBULIZATION
    Publication number: 20170326117
    Abstract: The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.
    Type: Application
    Filed: July 28, 2017
    Publication date: November 16, 2017
    Inventors: Ulhas DHUPPAD, Franciscus KOPPENHAGEN, Sunil CHAUDHARI, Suresh RAJURKAR, Chandrakant DHATRAK, Alkesh KASLIWAL
  • Tiotropium inhalation solution for nebulization
    Patent number: 9757365
    Abstract: The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: September 12, 2017
    Assignee: Glenmark Specialty S.A.
    Inventors: Ulhas Dhuppad, Franciscus Koppenhagen, Sunil Chaudhari, Suresh Rajurkar, Chandrakant Dhatrak, Alkesh Kasliwal
  • NANOPARTICULATE FORMULATION COMPRISING A mPGES-1 INHIBITOR
    Publication number: 20170135991
    Abstract: The present invention relates to a nanoparticulate formulation comprising a microsomal prostaglandin E synthases-1 (“mPGES-1”) inhibitor. Particularly, the present invention relates to a nanoparticulate formulation comprising an mPGES-1 inhibitor and one or more surface stabilizers; a process for preparing such formulation; and its use in treating pain and inflammation in a subject.
    Type: Application
    Filed: July 31, 2015
    Publication date: May 18, 2017
    Inventors: Ulhas R. DHUPPAD, Sunil CHAUDHARI, Suresh RAJURKAR, Nilesh JAIN, Chandrakant DHATRAK, Alkesh KASLIWAL
  • TIOTROPIUM INHALATION SOLUTION FOR NEBULIZATION
    Publication number: 20160339003
    Abstract: The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.
    Type: Application
    Filed: May 17, 2016
    Publication date: November 24, 2016
    Inventors: Ulhas DHUPPAD, Franciscus KOPPENHAGEN, Sunil CHAUDHARI, Suresh RAJURKAR, Chandrakant DHATRAK, Alkesh KASLIWAL